In this webinar, Daryl Cole will share insights into the high-throughput screening and analysis of antibody binding and functional characterization.

This will dramatically accelerate their antibody drug development,” explains Changchun Zha, chief executive of Biointron. The acceleration can be attributed to process reconstruction and ...

The rise of novel monoclonal antibody (mAb) formats has not only transformed the therapeutic landscape but also introduced new purification challenges. From bispecific antibodies to antibody–drug ...

The number of approved biologic drugs has risen steeply in the past ... the bottlenecks that stem from the DNA synthesis process in antibody discovery, Twist antibody optimization (TAO) services ...